Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹5,897 Cr₹4,221 Cr₹3,675 Cr₹3,290 Cr₹2,178 Cr
Adjustment ₹641 Cr₹878 Cr₹967 Cr₹1,131 Cr₹1,366 Cr
Changes In working Capital ₹-806 Cr₹-559 Cr₹-177 Cr₹372 Cr₹373 Cr
Cash Flow after changes in Working Capital ₹5,731 Cr₹4,540 Cr₹4,465 Cr₹4,793 Cr₹3,917 Cr
Cash Flow from Operating Activities ₹4,134 Cr₹3,238 Cr₹3,326 Cr₹3,755 Cr₹3,068 Cr
Cash Flow from Investing Activities ₹-2,988 Cr₹-2,389 Cr₹-1,872 Cr₹-2,387 Cr₹104 Cr
Cash Flow from Financing Activities ₹-1,200 Cr₹-958 Cr₹-1,600 Cr₹-1,240 Cr₹-2,949 Cr
Net Cash Inflow / Outflow ₹-55 Cr₹-109 Cr₹-146 Cr₹129 Cr₹224 Cr
Opening Cash & Cash Equivalents ₹561 Cr₹658 Cr₹790 Cr₹649 Cr₹508 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹5.56 Cr₹12 Cr₹13 Cr₹13 Cr₹10 Cr
Closing Cash & Cash Equivalent ₹512 Cr₹561 Cr₹658 Cr₹790 Cr₹742 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹121,591.2 Cr -0.1% 0.2% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics
MANKIND PHARMA ₹98,309.9 Cr 1.1% -7% 9.7% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-0.1%

0.2%

-2.1%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses